Celsion (CLSN) Misses Q1 EPS by 3c

Celsion (NASDAQ: CLSN) reported Q1 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $125 thousand versus the consensus estimate of $80 thousand.

Net cash used in operations was $4.7 million the first quarter of 2016 compared to $5.9 million in the same period of the prior year. The Company ended the first quarter of 2016 with $14.3 million of total cash and cash equivalents.

For earnings history and earnings-related data on Celsion (CLSN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c